Insulin Receptor Family Autoantibodies in Patients with Type B Insulin Resistance
The Journal of Clinical Endocrinology & Metabolism · 2026
DOI: 10.1210/clinem/dgaf692 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2026. Verfasst von Jennifer E Lee und 6 weiteren Autor:innen. Beteiligte Einrichtung: National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA. Hauptthemen laut MEDLINE: Autoantibodies, Insulin Resistance, Receptor, Insulin, Antigens, CD. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: German Federal Ministry of Economics and Technology, NIDDK NIH HHS, NIH HHS.
Abstract (Originalsprache)
Context
Type B insulin resistance (TBIR) is a rare autoimmune disorder characterized by insulin resistance (IR) secondary to insulin receptor autoantibodies (InsR-aAb). A paucity of clinical InsR-aAb assays and incomplete mechanistic understanding complicate diagnosis.
Objective
This study aimed to (1) validate clinical performance of an immune-luminometric InsR-aAb assay in a relatively large cohort; (2) evaluate its diagnostic accuracy and define thresholds for TBIR diagnosis; and (3) evaluate autoantibody profiles against InsR, type 1 IGF receptor (IGF-1R), and the insulin receptor-related receptor (IRRR) in TBIR and non-autoimmune IR.
Methods
We conducted a cross-sectional analysis of patients with TBIR and non-autoimmune IR. InsR-aAb, IGF-1R-aAb, and IRRR-aAb titers were measured using receptor-specific immune-luminometric assays. Receiver operating characteristic analyses assessed diagnostic performance of the InsR-aAb assay. Multivariate regression models evaluated associations between autoantibody titers and biomarkers of glycemia (glycated hemoglobin [HbA1c], glucose, insulin), growth (IGF-1 z-score [IGF-1z]), and pH regulation (bicarbonate, urine pH).
Results
In TBIR, higher InsR-aAb titers associated with increased HbA1c, glucose, insulin, and lower IGF-1z (all P < .0001); higher IRRR-aAb titers with lower CO2 (P = .04). An optimal InsR-aAb cutoff for distinguishing TBIR from non-autoimmune IR was determined (area under the curve [AUC] 0.96, sensitivity 91.3%, specificity 93.9%). In non-autoimmune IR, autoantibody titers were not associated with glycemia biomarkers; IGF-1z increased with mild IR (P = .005) and decreased with severe IR (P = .01).
Conclusion
This study validates an InsR-aAb assay in the largest TBIR cohort to date and identifies a novel association between IRRR-aAb and bicarbonate excretion. While InsR-aAb were detected in other IR disorders, pathogenic effects were specific to TBIR.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
- Institute for Experimental Endocrinology, Charité-Universitätsmedizin Berlin, Berlin D-10115, Germany.
- Department of Clinical Biochemistry, Odense University Hospital, Odense 5000, Denmark.
ORCID-Profile: Lutz Schomburg, Rebecca J Brown
Förderung
- German Federal Ministry of Economics and Technology
- NIDDK NIH HHS
- NIH HHS
- National Institute of Diabetes and Digestive and Kidney Diseases
- National Institutes of Health
Zitieren
APA
Lee, J. E., Chillon, T. S., Minich, W. B., Abel, B. S., Lightbourne, M., Schomburg, L., & Brown, R. J. (2026). Insulin Receptor Family Autoantibodies in Patients with Type B Insulin Resistance. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgaf692
Vancouver
Lee JE, Chillon TS, Minich WB, Abel BS, Lightbourne M, Schomburg L, et al. Insulin Receptor Family Autoantibodies in Patients with Type B Insulin Resistance. The Journal of Clinical Endocrinology & Metabolism. 2026. doi:10.1210/clinem/dgaf692
BibTeX
@article{Lee2026,
author = {Lee, Jennifer E and Chillon, Thilo S and Minich, Waldemar B and Abel, Brent S and Lightbourne, Marissa and Schomburg, Lutz and Brown, Rebecca J},
title = {Insulin Receptor Family Autoantibodies in Patients with Type B Insulin Resistance},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2026},
doi = {10.1210/clinem/dgaf692}
}
EUVIMED